Molecular Biotechnology Center, Department of Genetics, Biology and Biochemistry, University of Torino, Torino, Italy.
Mol Biol Cell. 2010 Mar 1;21(5):704-11. doi: 10.1091/mbc.e09-08-0744. Epub 2010 Jan 6.
Phosphoinositide 3-kinases (PI3K) are key molecular players in male fertility. However, the specific roles of different p110 PI3K catalytic subunits within the spermatogenic lineage have not been characterized so far. Herein, we report that male mice expressing a catalytically inactive p110beta develop testicular hypotrophy and impaired spermatogenesis, leading to a phenotype of oligo-azoospermia and defective fertility. The examination of testes from p110beta-defective tubules demonstrates a widespread loss in spermatogenic cells, due to defective proliferation and survival of pre- and postmeiotic cells. In particular, p110beta is crucially needed in c-Kit-mediated spermatogonial expansion, as c-Kit-positive cells are lost in the adult testis and activation of Akt by SCF is blocked by a p110beta inhibitor. These data establish that activation of the p110beta PI3K isoform by c-Kit is required during spermatogenesis, thus opening the way to new treatments for c-Kit positive testicular cancers.
磷酸肌醇 3-激酶(PI3K)是男性生育力的关键分子参与者。然而,迄今为止,不同的 p110 PI3K 催化亚基在精子发生谱系中的具体作用尚未得到表征。本文报道了表达无催化活性 p110β的雄性小鼠出现睾丸萎缩和精子发生受损,导致少精症和生育力缺陷的表型。对 p110β缺陷小管的睾丸检查表明,由于减数分裂前和减数分裂后细胞的增殖和存活缺陷,广泛丧失了精子发生细胞。特别是,p110β在 c-Kit 介导的精原细胞扩增中至关重要,因为 c-Kit 阳性细胞在成年睾丸中丢失,并且 c-Kit 抑制剂阻断了 SCF 对 Akt 的激活。这些数据表明,c-Kit 激活的 p110β PI3K 同工型在精子发生过程中是必需的,从而为治疗 c-Kit 阳性睾丸癌开辟了新的途径。